Knockdown of lncRNA PCAT6 suppresses the growth of non-small cell lung cancer cells by inhibiting macrophages M2 polarization via miR-326/KLF1 axis

References

• Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446–454.
   PubMed Web of Science ®Google Scholar
• Pennell NA, Arcila ME, Gandara DR, et al. Biomarker testing for patients with advanced non-small cell lung cancer: real-world issues and tough choices. American Society of Clinical Oncology educational book American Society of Clinical Oncology Annual Meeting, America. 2019; 39:531–542.
   Google Scholar
• Loeb LA, Ernster VL, Warner KE, et al. Smoking and lung cancer: an overview. Cancer Res. 1984;44(12 Pt 1):5940–5958.
   PubMed Web of Science ®Google Scholar
• Rivera GA, Wakelee H. Lung cancer in never smokers. Adv Exp Med Biol. 2016;893:43–57.
   PubMed Web of Science ®Google Scholar
• Molina JR, Yang P, Cassivi SD, et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. 2008; 83:584–594.
   Google Scholar
• Smith JA, Harle A, Dockry R, et al. Aprepitant for cough in lung cancer. a randomized placebo-controlled trial and mechanistic insights. Am J Respir Crit Care Med. 2021;203(6):737–745.
   PubMed Web of Science ®Google Scholar
• Malinowska K. The relationship between chest pain and level of perioperative anxiety in patients with lung cancer. Pol Przegl Chir. 2018;90(2):23–27.
   PubMedGoogle Scholar
• Ha D, Ries AL. Characterization of dyspnea in veteran lung cancer survivors following curative-intent therapy. J Cardiopulm Rehabil Prev. 2020;40(2):120–127.
   PubMed Web of Science ®Google Scholar
• Hoy H, Lynch T, Beck M. Surgical Treatment of Lung Cancer. Crit Care Nurs Clin North Am. 2019;31(3):303–313.
   PubMed Web of Science ®Google Scholar
• Rossi A, Di Maio M. Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles. Expert Rev Anticancer Ther. 2016;16(6):653–660.
   PubMed Web of Science ®Google Scholar
• Imyanitov EN, Iyevleva AG, Levchenko EV. Molecular testing and targeted therapy for non-small cell lung cancer: current status and perspectives. Crit Rev Oncol Hematol. 2021;157:103194.
   PubMed Web of Science ®Google Scholar
• Jonna S, Subramaniam DS. Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update. Discov Med. 2019;27(148):167–170.
   PubMed Web of Science ®Google Scholar
• Hirayama D, Iida T, Nakase H. The phagocytic function of macrophage-enforcing innate immunity and tissue homeostasis. Int J Mol Sci. 2017;19(1):92.
   PubMed Web of Science ®Google Scholar
• Chanput W, Mes JJ, Wichers HJ. THP-1 cell line: an in vitro cell model for immune modulation approach. Int Immunopharmacol. 2014;23(1):37–45.
   PubMed Web of Science ®Google Scholar
• Biriken D, Yazıhan N, Ş Y. [Investigation of cytokine and midkine responses of human THP-1 leukemia cells induced by phorbol-12-Myristate-13-Acetate (PMA) at different concentrations and times]. Mikrobiyoloji bulteni. 2018;52(2):147–155.
   PubMed Web of Science ®Google Scholar
• Funes SC, Rios M, Escobar-Vera J, et al. Implications of macrophage polarization in autoimmunity. Immunology. 2018;154(2):186–195.
   PubMed Web of Science ®Google Scholar
• Zhou D, Huang C, Lin Z, et al. Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell Signal. 2014;26(2):192–197.
   PubMed Web of Science ®Google Scholar
• Martinez FO, Sica A, Mantovani A, et al. Macrophage activation and polarization. Front Biosci. 2008;13(13):453–461.
   PubMed Web of Science ®Google Scholar
• Genin M, Clement F, Fattaccioli A, et al. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. BMC Cancer. 2015;15(1):577.
   PubMedGoogle Scholar
• Pan Y, Yu Y, Wang X, et al. Tumor-associated macrophages in tumor immunity. Front Immunol. 2020;11:583084.
   PubMed Web of Science ®Google Scholar
• He Y, Du J, Dong Z. Myeloid deletion of phosphoinositide-dependent kinase-1 enhances NK cell-mediated antitumor immunity by mediating macrophage polarization. Oncoimmunology. 2020;9(1):1774281.
   PubMed Web of Science ®Google Scholar
• Zeng XY, Xie H, Yuan J, et al. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression. Cancer Biol Ther. 2019;20(7):956–966.
   PubMed Web of Science ®Google Scholar
• Mukherjee K, Bieker JJ. Transcriptional control of gene expression and the heterogeneous cellular identity of erythroblastic island macrophages. Front Genet. 2021;12:756028.
   PubMed Web of Science ®Google Scholar
• Mukherjee K, Xue L, Planutis A, et al. EKLF/KLF1 expression defines a unique macrophage subset during mouse erythropoiesis. eLife. 2021;10. DOI:10.7554/eLife.61070
   Web of Science ®Google Scholar
• Wang J, Su Z, Lu S, et al. LncRNA HOXA-AS2 and its molecular mechanisms in human cancer. Clin Chim Acta. 2018;485:229–233.
   PubMed Web of Science ®Google Scholar
• Zhu J, Zhang X, Gao W, et al. lncRNA/circRNA‑miRNA‑mRNA ceRNA network in lumbar intervertebral disc degeneration. Mol Med Rep. 2019;20(4):3160–3174.
   PubMed Web of Science ®Google Scholar
• Wu X, Sui Z, Zhang H, et al. Integrated analysis of lncRNA-mediated cerna network in lung adenocarcinoma. Front Oncol. 2020;10:554759.
   PubMed Web of Science ®Google Scholar
• Zhen Q, Gao LN, Wang RF, et al. LncRNA DANCR Promotes Lung Cancer by Sequestering miR-216a. Cancer control: J Moffitt Cancer Center. 2018;25(1):1073274818769849.
   Web of Science ®Google Scholar
• Sun J, Zhang Z, Bao S, et al. Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer. J Immunother Cancer. 2020;e000110:8.
   Google Scholar
• Zhang YX, Yuan J, Gao ZM, et al. LncRNA TUC338 promotes invasion of lung cancer by activating MAPK pathway. Eur Rev Med Pharmacol Sci. 2018;22(2):443–449.
   PubMed Web of Science ®Google Scholar
• Wang S, Chen Z, Gu J, et al. The role of lncRNA PCAT6 in cancers. Front Oncol. 2021;11:701495.
   PubMed Web of Science ®Google Scholar
• Luo Y, Lin J, Zhang Y, et al. LncRNA PCAT6 predicts poor prognosis in hepatocellular carcinoma and promotes proliferation through the regulation of cell cycle arrest and apoptosis. Cell Biochem Funct. 2020;38(7):895–904.
   PubMed Web of Science ®Google Scholar
• Kong FR, Lv YH, Yao HM, et al. LncRNA PCAT6 promotes occurrence and development of ovarian cancer by inhibiting PTEN. Eur Rev Med Pharmacol Sci. 2019;23(19):8230–8238.
   PubMed Web of Science ®Google Scholar
• Cui LH, Xu HR, Yang W, et al. lncRNA PCAT6 promotes non-small cell lung cancer cell proliferation, migration and invasion through regulating miR-330-5p. Onco Targets Ther. 2018;11:7715–7724.
   PubMed Web of Science ®Google Scholar
• Lai F, Zhang H, Xu B, et al. Long non-coding RNA NBR2 suppresses the progress of colorectal cancer in vitro and in vivo by regulating the polarization of TAM. Bioengineered. 2021;12(1):5462–5475.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu J, Cui J, et al. Role of lncRNA LINC01194 in hepatocellular carcinoma via the miR-655-3p/SMAD family member 5 axis. Bioengineered. 2022;13(1):1115–1125.
   PubMed Web of Science ®Google Scholar
• Tan D, Li G, Zhang P, et al. LncRNA SNHG12 in extracellular vesicles derived from carcinoma-associated fibroblasts promotes cisplatin resistance in non-small cell lung cancer cells. Bioengineered. 2022;13(1):1838–1857.
   PubMed Web of Science ®Google Scholar
• Fu D, Zang L, Li Z, et al. Long non-coding RNA CRNDE regulates the growth and migration of prostate cancer cells by targeting microRNA-146a-5p. Bioengineered. 2021;12(1):2469–2479.
   PubMed Web of Science ®Google Scholar
• Han M, Gu Y, Lu P, et al. Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation. Mol Cancer. 2020;19(1):26.
   PubMed Web of Science ®Google Scholar
• Shou Y, Wang X, Liang Y, et al. Exosomes-derived miR-154-5p attenuates esophageal squamous cell carcinoma progression and angiogenesis by targeting kinesin family member 14. Bioengineered. 2022;13(2):4610–4620.
   PubMed Web of Science ®Google Scholar
• Huang H, Zhong P, Zhang J, et al. Human umbilical cord-mesenchymal stem cells-derived exosomes carrying microRNA-15a-5p possess therapeutic effects on wilms tumor via regulating septin 2. Bioengineered. 2022;13(3):6136–6149.
   PubMed Web of Science ®Google Scholar
• Ni Q, Zhang H, Shi X, et al. Exosomal microRNA-23a-3p contributes to the progression of cholangiocarcinoma by interaction with dynamin3. Bioengineered. 2022;13(3):6208–6221.
   PubMed Web of Science ®Google Scholar
• Che Z, Xueqin J, Zhang Z. LncRNA OIP5-AS1 accelerates intervertebral disc degeneration by targeting miR-25-3p. Bioengineered. 2021;12(2):11201–11212.
   PubMed Web of Science ®Google Scholar
• Wang R, Xu J, Xu J, et al. MiR-326/Sp1/KLF3: a novel regulatory axis in lung cancer progression. Cell Prolif. 2019;52(2):e12551.
   PubMed Web of Science ®Google Scholar
• Sun C, Huang C, Li S, et al. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development. Oncotarget. 2016;7(7):8341–8359.
   PubMedGoogle Scholar
• Bao H, Wang J, Zhou D, et al. Retracted article: protein–Protein interaction network analysis in chronic obstructive pulmonary disease. Lung. 2014;192(1):87–93.
   PubMed Web of Science ®Google Scholar
• Su G, Yan Z, Deng M. Sevoflurane inhibits proliferation, invasion, but enhances apoptosis of lung cancer cells by Wnt/β-catenin signaling via regulating lncRNA PCAT6/miR-326 axis. Open Life Sci. 2020;15(1):159–172.
   PubMed Web of Science ®Google Scholar
• Shi X, Liu Z, Liu Z, et al. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer. EBioMedicine. 2018;37:177–187.
   PubMed Web of Science ®Google Scholar
• Lee SS, Cheah YK. The interplay between micrornas and cellular components of Tumour Microenvironment (TME) on Non-Small-Cell Lung Cancer (NSCLC) progression. J Immunol Res. 2019;2019:3046379.
   PubMed Web of Science ®Google Scholar
• Weng YS, Tseng HY, Chen YA, et al. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer. Mol Cancer. 2019;18(1):42.
   PubMed Web of Science ®Google Scholar
• Sun Y, Xu J. TCF-4 regulated lncRNA-XIST promotes M2 polarization of macrophages and is associated with lung cancer. Onco Targets Ther. 2019;12:8055–8062.
   PubMed Web of Science ®Google Scholar
• Tu J, Wu F, Chen L, et al. Long non-coding RNA PCAT6 induces M2 polarization of macrophages in cholangiocarcinoma via modulating miR-326 and RhoA-ROCK signaling pathway. Front Oncol. 2020;10:605877.
   PubMed Web of Science ®Google Scholar
• Dong F, Ruan S, Wang J, et al. M2 macrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2. Cell Death Dis. 2020;11(9):728.
   PubMed Web of Science ®Google Scholar
• Li S, Li Y, Tan B, et al. Krüppel-like factor 1 serves as a facilitator in gastric cancer progression via activating the Wnt/β-catenin pathway. Acta Biochim Pol. 2021;68(4):765–774.
   PubMed Web of Science ®Google Scholar